Literature DB >> 27999520

Comorbidity in Multiple Sclerosis: Some Answers, More Questions.

Ruth Ann Marrie.   

Abstract

Entities:  

Year:  2016        PMID： 27999520      PMCID： PMC5166592          DOI： 10.7224/1537-2073.2016-086

Source DB:  PubMed          Journal:  Int J MS Care        ISSN： 1537-2073


× No keyword cloud information.
  13 in total

Review 1.  Causes and consequences of comorbidity: a review.

Authors:  R Gijsen; N Hoeymans; F G Schellevis; D Ruwaard; W A Satariano; G A van den Bos
Journal:  J Clin Epidemiol       Date:  2001-07       Impact factor: 6.437

2.  Gender and autoimmune comorbidity in multiple sclerosis.

Authors:  Melinda Magyari; Nils Koch-Henriksen; Claudia C Pfleger; Per Soelberg Sørensen
Journal:  Mult Scler       Date:  2014-02-05       Impact factor: 6.312

3.  Validity of four screening scales for major depression in MS.

Authors:  Scott B Patten; Jodie M Burton; Kirsten M Fiest; Samuel Wiebe; Andrew G M Bulloch; Marcus Koch; Keith S Dobson; Luanne M Metz; Colleen J Maxwell; Nathalie Jetté
Journal:  Mult Scler       Date:  2015-01-12       Impact factor: 6.312

4.  Examining the joint effect of disability, health behaviors, and comorbidity on mortality in MS.

Authors:  Amber Salter; Tuula Tyry; Guoqiao Wang; Robert J Fox; Gary Cutter; Ruth Ann Marrie
Journal:  Neurol Clin Pract       Date:  2016-10

5.  Influence of hypertension, diabetes, hyperlipidemia, and obstructive lung disease on multiple sclerosis disease course.

Authors:  Devon S Conway; Nicolas R Thompson; Jeffrey A Cohen
Journal:  Mult Scler       Date:  2016-07-11       Impact factor: 6.312

6.  Comorbidity delays diagnosis and increases disability at diagnosis in MS.

Authors:  R A Marrie; R Horwitz; G Cutter; T Tyry; D Campagnolo; T Vollmer
Journal:  Neurology       Date:  2008-10-29       Impact factor: 9.910

7.  Coping strategies, psychological variables and their relationship with quality of life in multiple sclerosis.

Authors:  Benedetta Goretti; Emilio Portaccio; Valentina Zipoli; Bahia Hakiki; Gianfranco Siracusa; Sandro Sorbi; Maria Pia Amato
Journal:  Neurol Sci       Date:  2009-01-20       Impact factor: 3.307

Review 8.  A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.

Authors:  Ruth Ann Marrie; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Per Soelberg Sørensen; Stephen Reingold; Gary Cutter; Nadia Reider
Journal:  Mult Scler       Date:  2015-01-26       Impact factor: 6.312

9.  Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis.

Authors:  Tingting Zhang; Helen Tremlett; Stella Leung; Feng Zhu; Elaine Kingwell; John D Fisk; Virender Bhan; Trudy L Campbell; Karen Stadnyk; B Nancy Yu; Ruth Ann Marrie
Journal:  Neurology       Date:  2016-03-04       Impact factor: 9.910

10.  The challenge of comorbidity in clinical trials for multiple sclerosis.

Authors:  Ruth Ann Marrie; Aaron Miller; Maria Pia Sormani; Alan Thompson; Emmanuelle Waubant; Maria Trojano; Paul O'Connor; Stephen Reingold; Jeffrey A Cohen
Journal:  Neurology       Date:  2016-02-17       Impact factor: 9.910
View more
  7 in total

Review 1.  Multiple Sclerosis Phenotypes as a Continuum: The Role of Neurologic Reserve.

Authors:  Timothy L Vollmer; Kavita V Nair; Ian M Williams; Enrique Alvarez
Journal:  Neurol Clin Pract       Date:  2021-08

2.  Education, and the balance between dynamic and stationary functional connectivity jointly support executive functions in relapsing-remitting multiple sclerosis.

Authors:  Sue-Jin Lin; Irene Vavasour; Brenda Kosaka; David K B Li; Anthony Traboulsee; Alex MacKay; Martin J McKeown
Journal:  Hum Brain Mapp       Date:  2018-09-21       Impact factor: 5.038

Review 3.  Neurofilaments: neurobiological foundations for biomarker applications.

Authors:  Arie R Gafson; Nicolas R Barthélemy; Pascale Bomont; Roxana O Carare; Heather D Durham; Jean-Pierre Julien; Jens Kuhle; David Leppert; Ralph A Nixon; Roy O Weller; Henrik Zetterberg; Paul M Matthews
Journal:  Brain       Date:  2020-07-01       Impact factor: 13.501

4.  Comorbidity and metabolic syndrome in patients with multiple sclerosis from Asturias and Catalonia, Spain.

Authors:  Antoni Sicras-Mainar; Elena Ruíz-Beato; Ruth Navarro-Artieda; Jorge Maurino
Journal:  BMC Neurol       Date:  2017-07-17       Impact factor: 2.474

5.  Development and validation of a claims-based measure as an indicator for disease status in patients with multiple sclerosis treated with disease-modifying drugs.

Authors:  Michael Munsell; Molly Frean; Joseph Menzin; Amy L Phillips
Journal:  BMC Neurol       Date:  2017-06-05       Impact factor: 2.474

6.  Progressive familial intrahepatic cholestasis type-3 and multiple sclerosis: lessons from comorbidity.

Authors:  Roberto De Masi; Stefania Orlando; Antonella De Donno
Journal:  Ann Clin Transl Neurol       Date:  2019-09-30       Impact factor: 4.511

7.  Blood pressure and body fat percent in women with NMOSD.

Authors:  Xiaohong Chen; Rong Fan; Fuhua Peng; Jia Liu; Jing Huang; Zhigang Chen; Yong Chen; Ying Jiang
Journal:  Brain Behav       Date:  2019-08-03       Impact factor: 2.708
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.